Concert Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-12,815
Closed -$721K 366
2017
Q1
$721K Sell
12,815
-2,325
-15% -$136K 0.16% 181
2016
Q4
$852K Sell
15,140
-4,566
-23% -$263K 0.19% 160
2016
Q3
$1.21M Buy
19,706
+1,721
+10% +$113K 0.15% 176
2016
Q2
$1.14M Buy
17,985
+1,045
+6% +$65.7K 0.15% 182
2016
Q1
$1.02M Sell
16,940
-879
-5% -$53.8K 0.14% 192
2015
Q4
$1.24M Sell
17,819
-517
-3% -$36.7K 0.17% 151
2015
Q3
$1.22M Sell
18,336
-13,154
-42% -$1.02M 0.17% 155
2015
Q2
$2.47M Sell
31,490
-3,660
-10% -$285K 0.32% 63
2015
Q1
$2.2M Sell
35,150
-116
-0.3% -$8.53K 0.63% 32
2014
Q4
$2.35M Buy
35,266
+2,260
+7% +$151K 0.36% 54
2014
Q3
$2.1M Sell
33,006
-23,302
-41% -$1.44M 0.28% 38
2014
Q2
$3.35M Sell
56,308
-1,343
-2% -$77.9K 0.41% 15
2014
Q1
$3.2M Sell
57,651
-2,908
-5% -$165K 0.4% 18
2013
Q4
$3.23M Buy
60,559
+23,784
+65% +$1.19M 0.41% 16
2013
Q3
$1.7M Sell
36,775
-231
-0.6% -$10.5K 0.24% 54
2013
Q2
$1.56M Buy
+37,006
New +$1.54M 0.23% 46

Other funds holding PJP

Concert Wealth Management's PJP Position: Q2 2017 in Review

Concert Wealth Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2017, closing a stake of 12,815 shares — an estimated $721K sold.

Concert Wealth Management first reported a position in PJP in Q2 2013 and held it in 16 quarters. The position peaked at $3.35M in Q2 2014. 99 funds tracked by Wall St. Rank hold PJP as of Q2 2017.

  • Concert Wealth Management reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2017 after selling out during the quarter.
  • Concert Wealth Management sold 12,815 Invesco Pharmaceuticals ETF shares in Q2 2017, an estimated $721K.
  • Concert Wealth Management first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and held it in 16 quarters.
  • Concert Wealth Management's Invesco Pharmaceuticals ETF position peaked at $3.35M in Q2 2014.
  • 99 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2017.

Based on Concert Wealth Management's 13F filing for Q2 2017, filed 10 Aug 2017.